Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

NACDS observes Women’s Health Month and Mental Health Awareness Month

May campaign highlights NACDS members’ support of Nourish My Health.

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is observing Women’s Health Month and Mental Health Awareness Month with a focus on nutrition and its role in promoting overall health and wellness. As part of NACDS’ ongoing Nourish My Health public education campaign, NACDS is showcasing participating member pharmacies and their commitment to providing services and solutions at over 25,000 pharmacy locations across the country.

“We recognize the vital role that pharmacy teams play in advancing women’s health and addressing mental health issues with a practical and scalable approach,” said NACDS president and CEO Steven Anderson. “With a focus on delivering trusted, convenient care, pharmacies are the ideal destination for comprehensive services that include information and education about these critical health issues.”

Nourish My Health ‒ a collaboration with leading national health organizations ‒ was developed by NACDS in 2023 as part of a national strategy to end hunger, improve nutrition, and reduce disease. Nourish My Health encourages baseline health screening to understand disease risks; offers healthy food guides and nutrition information; provides resources for professionals; and hosts a nutrition security survey which informs meaningful access solutions.

View the content on Facebook, LinkedIn and X and share with the official campaign hashtag, #NourishMyHealth.

View recent NACDS digital content for Health Starts Here (January), Heart Health Month (February), and National Nutrition Month (March).  

Latest

Cencora settles suit over alleged opioid mismanagement

Cencora settles suit over alleged opioid mismanagement

The lawsuit brought by pension funds accused Cencora’s leadership of ignoring red flags around how the company was dispensing the highly addictive painkillers for years — including dubiously large opioid shipments — and failing to properly monitor opioid sales.